Publications by authors named "P Fiaschetti"

The post-organ transplant immunosuppressive therapy includes the administration of tacrolimus (Tac) or cyclosporine (CsA), along with antimetabolites (Antim) or mTOR inhibitors, with or without prednisone. A survey was conducted to investigate clinical experience regarding the use, efficacy, safety profile, and determinants of choice of maintenance immunosuppressive therapies. The questionnaire was sent to healthcare workers of 45 transplant centers specializing in kidney (K), liver (L), heart (H), and lung (P) transplants.

View Article and Find Full Text PDF
Article Synopsis
  • Living donor kidney transplantation (LDKTx) is endorsed by scientific societies for its effectiveness, with 40,663 kidney transplants done in Italy from 2001 to 2022, including 4731 from living donors.
  • The study found no postoperative deaths among living donors, and a high 10-year donor survival rate of 93.38%, though 1.8% of donors developed renal disease post-surgery.
  • The survey revealed that while many transplant centers use minimally invasive techniques and safety checklists, there is a need for improved donor safety protocols and increased experience among surgical teams in Italy.
View Article and Find Full Text PDF

Background: Multiple barriers diminish access to kidney transplantation (KT) in immigrant compared to non-immigrant populations. It is unknown whether immigration status reduces the likelihood of KT after wait-listing despite universal healthcare coverage with uniform access to transplantation.

Methods: We retrospectively collected data of all adult waiting list (WL) registrants in Italy (2010-20) followed for 5 years until death, KT in a foreign center, deceased-donor kidney transplant (DDKT), living-donor kidney transplant (LDKT) or permanent withdrawal from the WL.

View Article and Find Full Text PDF

Background: Rare diseases (RDs) are a heterogeneous group of pathologies, which, when present in a donor, with their anatomic or functional deficiencies, may put the recipient at risk. The aim of our work is to analyze the incidence of RDs in our donors to support transplant experts in the evaluation of these organs.

Methods: We retrospectively assessed the incidence of RDs in donors from July 2017 to June 2019, along with the risk attributed, the number of transplanted organs, and the follow-up results of the recipients.

View Article and Find Full Text PDF

Background: The national protocol for the handling of high-urgency (HU) liver organ procurement for transplant is administered by the Italian National Transplant Center. In recent years, we have witnessed a change in requests to access the program. We have therefore evaluated their temporal trend, the need to change the access criteria, the percentage of transplants performed, the time of request satisfaction, and the follow-up.

View Article and Find Full Text PDF